LCAT, lecithin-cholesterol acyltransferase, 3931

N. diseases: 94; N. variants: 41
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020473
Disease: Hyperlipidemia
Hyperlipidemia
0.220 Biomarker disease BEFREE Selenium and magnesium co-supplementation remarkably inhibited the mRNA expression level of hepatic lipogenesis genes liver X receptor alpha (LXRα),SREBP-1c and FASN (fatty acid synthase), regulated the mRNA expression levels of liver enzymes related to cholesterol metabolism, including the down regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) and the upregulation of cholesterol 7α-hydroxylase (CYP7A1) and lecithin cholesterol acyltransferase (LCAT) in the liver of hyperlipidemia rats. 30031400 2018
CUI: C0020473
Disease: Hyperlipidemia
Hyperlipidemia
0.220 Biomarker disease RGD Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats. 12935429 2003
CUI: C0020473
Disease: Hyperlipidemia
Hyperlipidemia
0.220 AlteredExpression disease LHGDN Endotoxin-lipoprotein complex formation as a factor in atherogenesis: associations with hyperlipidemia and with lecithin:cholesterol acyltransferase activity. 12139471 2002